Chi-Hsiao Yeh
Biochemistry — Linkou Chang Gung Memorial Hospital, Taiwan
Chi-Hsiao Yeh
LeadR Profile
Biochemistry
Subspecialties: Cardiology - Surgery - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2002 - 2026
Number : 93
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Positron emission tomography-guided planning is associated with improved outcomes after thoracic endovascular aortic repair in T4b esophageal cancer. tomography, positron-emission tomography, neoplasms, esophageal neoplasms | J Vasc Surg | 2026 | 0 |
| Comparison of short-term outcomes in open versus endovascular management of traumatic axillosubclavian arterial injuries in the contemporary era: a systematic review and meta-analysis. mortality, stroke, surgical procedures, operative, amputation, surgical, thrombosis, wounds and injuries | World J Emerg Surg | 2026 | 0 |
| Operative and hemostatic differences between acute type A intramural hematoma and aortic dissection. mortality, confidence intervals, hematoma, probability, hemostatics, hospital mortality, odds ratio, therapeutics, general surgery, aortic dissection, dissection | Surgery | 2026 | 0 |
| Maternal and neonatal outcomes in Marfan syndrome: a nationwide registry. registries, pregnancy, mortality, heart diseases, parturition, incidence, marfan syndrome, gestational age, birth weight, maternal mortality | Heart | 2025 | 0 |
| Optimizing blood pressure control in multimorbid hypertensive patients: insights from a real-world taiwanese cohort. diabetes mellitus, hypertension, mortality, blood, calcium channel blockers, myocardial infarction, blood pressure, angiotensin receptor antagonists, diuretics, vasodilator agents | J Hypertens | 2025 | 0 |
Clinical Studies 6
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Validating Integrative Multi omics Approaches in Metabolic Syndrome related Diseases NCT07248371 — liver diseases, kidney diseases, genomics, non-alcoholic fatty liver disease, cardiovascular diseases, multiple chronic conditions, kidney, liver, alcoholics, machine learning, metabolomics, obesity, precision medicine, learning, overweight, fatty liver, renal insufficiency, metabolic syndrome, fatty liver, alcoholic, renal insufficiency, chronic | N/A | Recruiting | 2025 |
LeadR Networks
Main global connection map